GMP Manufacturing Services

Utilizing custom design and development
to achieve regulatory approval

ABL has a long and successful history as a CDMO providing contract development and GMP biomanufacturing services to the biotech and biopharmaceutical industry. Our primary focus is viral vector manufacturing and we operate GMP facilities in the U.S. and Europe to meet your global regulatory and redundancy requirements. ABL offers a comprehensive portfolio of effective design, development, production and testing services for a broad range of virus products.

The success of your novel product starts with ABL

ABL’s 30+ years of viral-vector development and GMP production accelerates your novel gene therapies, vaccines, oncolytics and immunotherapies.

30+

YEARS OF EXPERIENCE

200+

CLIENTS

250+

GMP LOTS

Viral Vector Manufacturing Experts

Our product types

We are a biomanufacturing corporation with global facilities, suites and production platforms focused on accelerating your life changing innovation to market
Gene Therapies
oncolytic vectors
Oncolytics
vaccines
Vaccines
immunotherapies
Immunotherapies

Experience producing numerous viral vectors for

Gene therapies | Vaccines | Oncolytics | Immunotherapies

HSV-1

Vaccinia
(and MVA)

VLPs

Zika

CMV

Lentivirus
(and Retrovirus)

Adenovirus

AAV

VSV

When developing life changing innovations,
the right strategic partner makes the difference

Comprehensive GMP Manufacturing Support

Process design

Process feasibility

Upstream and/or downstream process development

Assay development and qualification

Master and working cell and virus banks

Scale-up and engineering run(s)

GMP bulk drug substance

GMP aseptic fill/finish

Analytical lot release testing

ICH stability testing

Chemistry, manufactoring and controls support

Quality systems

Quality systems and scientific depth

ABL’s U.S. location adheres to Good Manufacturing Practice (GMP) standards and is ISO 9001 accredited. ABL Europe’s facilities are regularly inspected by the French regulatory authorities (ANSM) and is a GMP licensed site for the manufacture of drug substance and aseptically prepared small volume liquid (drug product) viral products in accordance with EMA regulations.

Global GMP Manufacturing Facilities

Our U.S. and European compliant facilities are available for GMP production of clinical, pre-clinical trials, and commercial material with iCELLis 500+ platform ready for use. See our New Capabilities.

Learn about our biomanufacturing services

In addition to the services listed above, ask about our protein manufacturing and GMP antibody production services.

Specialist ready to execute. Let’s start the discussion today.